bosentan monohydrate
SpainDrugs containing this active substance
-
It is used to treat pulmonary arterial hypertension (PAH), a disease that narrows the blood vessels in the lungs, and to reduce the number of new ulcers on the fingers and toes in patients with scleroderma.
Form: tablets, film-coated
Active substance Dosage bosentan monohydrate 129,082 mg Manufacturer: Aurovitas Spain, S.A.U.
-
It is used to treat pulmonary arterial hypertension (PAH), a disease that narrows the blood vessels in the lungs, and to reduce the number of new ulcers on the fingers and toes in adult patients with scleroderma.
Form: tablets, film-coated
Active substance Dosage bosentan monohydrate 64,541 mg Manufacturer: Aurovitas Spain, S.A.U.
-
It is used to treat pulmonary arterial hypertension (PAH), a disease that narrows the blood vessels in the lungs. It is also used to reduce the occurrence of new ulcers on the fingers and toes in adults with scleroderma.
Form: tablets, film-coated
Active substance Dosage bosentan monohydrate 129,080 mg Manufacturer: Cipla Europe N.V.
-
It is used to treat pulmonary arterial hypertension (PAH), a disease that narrows the blood vessels in the lungs, and to reduce the number of new ulcers on the fingers and toes in adult patients with scleroderma.
Form: tablets, film-coated
Active substance Dosage bosentan monohydrate 64,540 mg Manufacturer: Cipla Europe N.V.
-
It is used to treat pulmonary arterial hypertension (PAH) in patients with marked limitation of physical activity (class III) and to reduce the number of new digital ulcers in the hands and feet in adults with scleroderma.
Form: tablets, film-coated
Active substance Dosage bosentan monohydrate 129,082 mg Manufacturer: Kern Pharma S.L.
-
It is used to treat pulmonary arterial hypertension (PAH) in patients with physical activity limitation and to reduce the number of new ulcers on the fingers and toes in adults with scleroderma.
Form: tablets, film-coated
Active substance Dosage bosentan monohydrate 64,541 mg Manufacturer: Kern Pharma S.L.
-
It is used to treat pulmonary arterial hypertension (PAH), a disease that narrows the blood vessels in the lungs, and to reduce the number of new ulcers on the fingers and toes in adult patients with scleroderma.
Form: tablets, film-coated
Active substance Dosage bosentan monohydrate 129,1 mg Manufacturer: Laboratorios Normon S.A.
-
It is used to treat pulmonary arterial hypertension (PAH), a disease that narrows the blood vessels in the lungs, and to reduce the number of new ulcers on the fingers and toes in adults with scleroderma.
Form: tablets, film-coated
Active substance Dosage bosentan monohydrate 64,55 mg Manufacturer: Laboratorios Normon S.A.
-
It is used to treat pulmonary arterial hypertension (PAH) to improve symptoms and the ability to perform physical activity, and also to treat digital ulcers in the fingers and toes of adult patients with scleroderma.
Form: tablets, film-coated
Active substance Dosage bosentan monohydrate 129,082 mg Manufacturer: Sandoz Farmaceutica S.A.
-
It is used to treat pulmonary arterial hypertension (PAH), a disease that narrows the blood vessels in the lungs, and to treat digital ulcers (in the fingers and toes) in adults with scleroderma.
Form: tablets, film-coated
Active substance Dosage bosentan monohydrate 129,083 mg Manufacturer: Sun Pharmaceutical Industries (Europe) B.V.
-
It is used to treat pulmonary arterial hypertension (PAH), a disease that narrows the blood vessels in the lungs, and to reduce the number of new ulcers on the fingers and toes in adult patients with scleroderma.
Form: tablets, film-coated
Active substance Dosage bosentan monohydrate 64,541 mg Manufacturer: Sun Pharmaceutical Industries (Europe) B.V.
-
It is used to treat pulmonary arterial hypertension (PAH) to improve symptoms and the ability to perform physical activity, and also to treat digital ulcers in the fingers and toes of adults with scleroderma.
Form: tablets, film-coated
Active substance Dosage bosentan monohydrate 129,082 mg Manufacturer: Janssen-Cilag International N.V
-
It is used to treat pulmonary arterial hypertension (PAH), a disease that narrows the blood vessels in the lungs, and to reduce the number of new ulcers in the fingers and toes in adults with scleroderma.
Form: tablets, film-coated
Active substance Dosage bosentan monohydrate 64,541 mg Manufacturer: Janssen-Cilag International N.V